Track the WuXi Biologics (Cayman) Inc. stock price and the full management transaction log of the company, a listed equity based in Hong Kong. Shares are quoted on the HK market, under the supervision of HKEX. Operating in the Health Care sector, WuXi Biologics (Cayman) Inc. has logged 16 reports. Market capitalisation: €204.4bn. The latest transaction was filed on 10 September 2026 (Other). Among the most active insiders: Chen Zhisheng. The full history is accessible without an account.
16
Insider Decl.
n/a
Thresholds
n/a
3 ops.
Buy Volume
€8m
1 ops.
Sell Volume
Analyst consensus: bullish or bearish?
Analysts rate WuXi Biologics (Cayman) Inc. Buy (bullish), based on 24 analysts. Average price target: HK$56.15.
23Σ signal
Buys n/a€8m Sells
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 12,050 of 29,064 companies
56.3
score / 100
Value
37
Quality
75
FCF yld1.3%
Earn yld2.4%
EV/EBITDA23.5x
ROE11%
Gross mgn46%
Net mgn23%
Debt/EBITDA0.4x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.